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Abstract The increase in allergic disease prevalence has
led to heightened interest in the factors determining
allergy risk, fuelled by the hope that by influencing these
factors one could reduce the prevalence of allergic
conditions. The most important modifiable risk factors
for allergy are maternal smoking behaviour and the type
of feeding. A smoke-free environment for the child (to
be), exclusive breastfeeding for 4–6m o n t h sa n dt h e
postponement of supplementary feeding (solids) until
4 months of age are the main measures considered
effective. There is no place for restricted diets during
pregnancy or lactation. Although meta-analyses suggest
that hypoallergenic formula after weaning from breast-
feeding grants protection against the development of
allergic disease, the evidence is limited and weak.
Moreover, all current feeding measures aiming at allergy
prevention fail to show effects on allergic manifestations
later in life, such as asthma. In conclusion, the allergy
preventive effect of dietary interventions in infancy is
limited. Counselling of future parents on allergy preven-
tion should pay attention to these limitations.
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Introduction
In the second half of the twentieth century, the prevalence
of immunoglobulin E (IgE)-mediated allergic conditions in
the Western World has doubled [5]. The prevalence of
allergic disease, in particular wheezing and asthma, varies
considerably throughout the world, with the highest risk in
Western countries [60]. It is assumed, therefore, that
Western lifestyle increases the risk of development of
allergic diseases [5, 60]. Although the identification of the
factors responsible for this rise in allergy prevalence is
important for allergy prevention, it is still largely unclear
which environmental aspects are involved [22]. In this
article, we briefly summarise the present knowledge on risk
factors for allergic disease and provide an overview of the
literature on allergy prevention, focussing on breastfeeding.
This should serve as a foundation for the advice health care
professionals provide to parents of children at increased risk
of allergy.
Definitions
According to the 2003 nomenclature revision, allergy is
defined as a hypersensitivity reaction initiated by specific
immunologic mechanisms, with hypersensitivity being
defined as causing objectively reproducible symptoms or
signs initiated by exposure to a defined stimulus at a
dose tolerated by normal persons [30]. Atopy is defined
as a personal and/or familial tendency, usually in child-
hood or adolescence, to become sensitised and produce
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allergens, usually proteins [30]. In the context of this
paper, ‘allergy’ refers to IgE-mediated or type I allergy,
which is associated with atopy. For newborns, the risk of
becoming atopic increases with the presence of atopy in
first-degree family members [2]. Likewise, ‘high-risk
infants’ are defined as those children who have one or
more first-degree relatives with proven allergic disease,
including food allergy, atopic eczema, allergic asthma and
rhinoconjunctivitis and, therefore, are at increased risk of
developing atopy and allergic disease.
Factors contributing to allergy risk
Genetic factors
IgE-mediated allergy has a strong hereditary component. It
is more common in monozygotic than in dizygotic twins
[2]. Our current knowledge of the role of genetic factors in
allergy development is summarised in Table 1. Allergic
diseases are considered complex genetic conditions, with
involvement of many genes and environmental factors [7].
The genetic factors involved in different allergic conditions
differ considerably. Notably, the genes involved in eczema
are more closely linked to those in other skin conditions
than to those in other allergic diseases [28, 50].
The practical usefulness of these observations is,
however, limited. Presently, the only way to use genetics
regarding allergy prevention is by identifying increased
allergy risk based on positive family history, in particular
for the same condition [2]. Generally, therefore, allergy
prevention is aimed at these ‘high-risk infants’ [32].
Hygiene hypothesis
The hygiene hypothesis postulates that the increased
prevalence of allergy is caused by reduced exposure to
microbial stimuli in early life, resulting in insufficient
stimulation of regulatory T cells [7, 53, 64]. The term was
coined in 1989 by Strachan, who observed that the more
older siblings a child had, the lower the risk of allergic
rhinitis [57]. A detailed description of the large body of
observational evidence supporting the hygiene hypothesis
can be found elsewhere [6].
Although early exposure to microbial stimuli shapes
the maturation of the neonatal immune system [25], this
concept has not yet yielded effective measures for allergy
prevention. BCG immunisation of newborns, for example,
does not decrease allergy risk [38, 43]. Although a Finnish
study showed up to 50% reduction of eczema risk in
infants of mothers using probiotics in late pregnancy and
during lactation [31], this has not been confirmed in
comparable studies [1, 59], and a recent Cochrane review
concluded probiotics to be ineffective in preventing
allergic disease [49].
Maternal food consumption
Although there is consensus that pregnant women should
not follow elimination diets [34], maternal food consump-
tion may still influence allergy risk in the offspring. For
instance, there is some evidence that in children of mothers
who were consuming fish at least once a week during
pregnancy, the risk of eczema and allergic rhinitis in
decreased [68], whereas daily (as opposed to incidental)
maternal consumption of nuts or peanuts was associated
with increased asthma risk [69]. These results would be
consistent with the hypothesis that a disturbed equilibrium
between n−3 and n−6 polyunsaturated fatty acid intake may
cause an Th1–Th2 imbalance [61, 69].
Cigarette-smoke exposure
The risk of asthma and poor lung function is considerably
higher when the mother smokes during pregnancy and
when after birth the infant is exposed to cigarette smoke
[10, 11, 36, 40, 71]. The association of smoking with other
allergic conditions, such as eczema and allergic rhinitis, is
less clear. Nevertheless, tobacco-smoke exposure is the
most readily available modifiable risk factor for allergic
disease in children, and every effort to help pregnant
women to stop smoking is worthwhile.
Other environmental factors
Although allergy risk appears to be largely determined in
the first few months of life, other environmental factors
may play additional roles later in life. Several factors have
been implicated, but the evidence is weak and limited.
Exposure to antibiotics [39] and paracetamol [42, 70] in the
first years of life may increase the risk of asthma. To what
extent consumption of certain foods and nutrients by the
child could influence the risk of allergic manifestations
remains to be determined [61].
Table 1 Allergic conditions and heredity
All allergic conditions have a genetic background [7]
Every allergic condition is influenced by several genetic factors [7]
The genetic factors of different allergic conditions differ considerably—
e.g., the genetic factors that are relevant to eczema are more similar
to those of other skin conditions than to those of other allergic
diseases [28, 50]
The increased prevalence of allergic disease in the Western world
cannot be explained genetically [5]
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There is no discussion on the fact that breastfeeding is the
optimal nutrition for infants [17], preferably exclusive
breastfeeding and preferably up to the age of 6 months
[17]. Despite the large body of evidence on the role of
breastfeeding in the prevention of allergy, however,
discussion on its allergy preventive effects continues,
mainly because of methodological issues.
Why is it so difficult to obtain evidence?
A principal problem with all studies on the effect of
breastfeeding on allergy prevention is that randomised
controlled trials (RCTs) are impossible. By consequence,
all studies in this field are observational [46, 65] and
subject to several confounding factors and biases [46].
Firstly, the multi-factorial nature of allergic diseases implies
that the modification of one single cause (breastfeeding)
will only have limited effects. Secondly, recall bias plays a
role in many studies that record feeding practices retro-
spectively. Furthermore, the statistical approach itself may
unwantedly adjust for secondary factors considered con-
founders that actually are part of the causal pathway—or
the other way around. In addition, genetic background may
considerably influence the association between breastfeed-
ing and allergy risk [46].
A major limitation of observational breastfeeding studies
is ‘confounding by behaviour’. Since the prevailing opinion
is that breastfeeding decreases the allergy risk, the mothers
of high-risk infants may be more inclined to breastfeeding
than those of low-risk infants. Indeed, an increased
incidence of allergic disease in intentionally breastfed
children has been found in some studies [8, 29]. The fact,
therefore, that systematic reviews nevertheless show an
inverse relationship between breastfeeding and allergic
disease suggests that the actual protective effect of
breastfeeding could even be higher than reported.
Why would breastfeeding reduce allergy risk?
The biological plausibility of the allergy preventive effect
of breastfeeding has been studied in a number of ways.
Firstly, breast milk contains traces of food proteins
consumed by the mother that could promote tolerance to
these foods [56]. Other factors in human milk that may
modulate mucosal immune processes include IgA, factors
that promote gut maturation, oligosaccharides, nucleotides
and leukocytes that control the growth of intestinal micro-
biota and long-chain polyunsaturated fatty acids [46]. For
example, n−3 fatty acids have anti-inflammatory and
immune modulating properties that could reduce allergy
risk [14].
Studies in weaning piglets have provided additional
evidence that breast milk may provide protection [51].
Several milk peptides were found to be able to down-
regulate neonatal immune activity, suggesting that they may
promote neonatal immune competence.
Does breastfeeding have a preventive effect?
Systematic reviews and meta-analyses of observational
studies consistently show a protective effect of exclusive
breastfeeding up to the age of at least 4 months [19, 45, 63,
65]. For example, one systematic review reported a
decrease of asthma in children up to the age of 8 years of
27% in the general population, increasing to 48% in high-
risk children [20]. Later, observational studies confirmed
the protective effect of exclusive breastfeeding on early life
manifestations of allergy, with little or no support, however,
to the notion that asthma later in life might be prevented as
well [16, 41]. It has been suggested that contrarily, asthma
risk at later age might even be increased in breastfed high-
risk children. This has recently been refuted, however, by a
very large epidemiological survey from the UK [46].
As noted earlier, all observational studies on the allergy
preventive effect of breastfeeding are subject to bias.
Obviously, the same applies to systematic reviews and
meta-analyses of such studies. To our knowledge the only
study that approaches an RCT design is from Belarus [35].
In this cluster-randomised trial, maternity hospitals were
randomised to implementation of the ‘Baby Friendly
Initiative’ campaign of the WHO. Although breastfeeding
in the first 3 months of life was seven times more common
in the intervention group, there was no difference between
intervention and control groups with regard to the preva-
lence of allergic disease and of positive skin prick tests up
to the age of 6 years [35]. Although these results may not
be considered representative of the Western situation, the
study confirms that at the least, breastfeeding does not
increase the prevalence of allergic disease in high-risk
children.
Other preventive measures
Complementary bottle feeding in the neonatal period
A large Dutch randomised trial in an unselected population
of breastfed infants showed that exposure to standard
formula in the first days of life did not increase the
prevalence of allergic disease [13]. There is no reason,
therefore, to provide hypoallergenic formula to breastfed
low-risk infants who need complementary formula. This
also holds for high-risk infants, although it seems be
counter-intuitive to give standard formula in this situation.
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Sooner or later, most breastfeeding mothers switch to
formula feeding. In contrast to breastfeeding, it is perfectly
possible to design RCTs for the comparison of the allergy
prevention effects of standard formula with those of
hypoallergenic (hydrolysed) formula. Systematic reviews
of RCTs conclude that both partially and extensively
hydrolysed formulas have a protective effect, in particular
on atopic eczema in the first years of life [23, 45]. Based on
this, several national and international organisations have
issued the advice that high-risk children who are not
breastfed should be given hypoallergenic formula in the
first 3 to 6 months of life [26, 32, 45].
There seems to be a change of wind, however. Because
the author of some of the most convincing studies has been
accused of scientific fraud [54], the weight of the evidence
has become a matter of discussion. As a result, the
conclusions of the original 2003 Cochrane analysis were
modified to conclude that: “In high risk infants who are
unable to be completely breast fed, there is limited evidence
that prolonged feeding with a hydrolysed formula com-
pared to a cow’s milk formula reduces infant and childhood
allergy and infant CMA”, the word ‘limited’ being added
[47]. An international expert group, however, opposed to
this weakened conclusion, reinforcing their original state-
ment [45] that high-risk infants should use hypoallergenic
formula once breastfeeding was not available [27].
How should we judge this discrepancy? It has been
pointed out that the quality of the evidence is weak. Table 2
summarises the most important methodological drawbacks
of the studies on hypoallergenic formula [9]. Clearly, the
pathophysiological model that prompted the use of hypo-
allergenic formula is no longer valid. The notion that
exposure to allergens results in sensitisation and that
subsequent repeated exposure causes disease is outdated.
Neither for airborne allergens nor for food allergens has a
clear relationship been proven between allergen exposure
and allergic disease development [13, 37]. Sensitisation to
foods has been found in children who never consumed the
actual food. Even the first documented contact with food
allergens may result in allergic reactions [44]. The
avoidance of exposure to airborne allergens such as house
dust mite does not prevent house dust mite allergy and
asthma [12]. Finally, it is unclear whether and how
hypoallergenic formula could influence regulatory T-cell
function [9].
There are more unsolved problems posed by intervention
studies with hypoallergenic formula. Objective endpoints,
such as serum concentrations of specific IgE against
common allergens, have never been shown to differ
between intervention and control groups [9]. It is likely
that any protection from allergy primarily involves mild
cases. With longer follow-up, the effect size of protection
appears to decrease, suggesting that allergic manifestations
are delayed rather than truly prevented [9]. The risks of
prolonged use of hypoallergenic formula have been poorly
studied [62]. A recent large observational ‘real life’ study
from the Netherlands showed that the delayed introduction
of cow’s milk in the diet of high-risk infants was associated
with increased atopy risk at the age of 2 years [55]. Long-
term allergen avoidance in itself may induce the ‘activation’
of allergy in sensitised children [18]. As a result, the risk–
benefit ratio of hypoallergenic formula use is unknown [9].
Considering all of the above, we tend to counsel parents
of high-risk infants as follows: we encourage exclusive
Table 2 Methodological problems in the studies with regard to the
effects of hydrolysed formula on allergy in high-risk children [9]
Blinding—differences in taste and smell prevent adequate blinding
of the parents, [21] which may compromise the appreciation of
subjective symptoms and even lead to ‘deblinding’ of the researchers
Heterogenicity—studies differ strongly with respect to criteria for
allergic disease and hypoallergenicity of formula [45]
Confounders—insufficient control for confounding variables
Compliance—bad smell and taste of hypoallergenic formula may
result in low compliance
Severity of disease—prevention may be particularly effective for
(very) mild cases
Postponement or cancellation—the effects of nutritional measures
shrink with longer follow-up and may even reverse
Mechanism—pathophysiological mechanism is unclear
All infants
Exclusive breastfeeding for at least the first 4 months of life
Continuation of breastfeeding up to 6 months of life
Complete avoidance of exposure to cigarette smoke, before as well as after birth
Introduction of supplementary feeding starting between 4 and 6 months of life
High-risk infants (positive family history)
Children who are not breastfed (anymore) should be given hydrolysed formula until 4 months of life
Partially hydrolysed formula is preferable above extensively hydrolysed formula
The parents should appreciate the limited effects of these measures
Table 3 Summary of allergy
prevention recommendations
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breastfeeding, hypoallergenic formula may postpone man-
ifestations of atopic eczema during the first 2 years of life
and there is no reason to prefer extensively hydrolysed
above partially hydrolysed formula [32, 47].
Introduction of complementary feeding
Until recently, it was common use to postpone the
introduction of complementary feeding (solids) as part of
allergy prevention measures until the age of 6 months [32].
This is in line with the WHO advice, aiming at exclusive
breastfeeding for the first half year of life. There is no
proof, however, that any further decrease of allergy risk is
obtained by postponing the introduction of solids until after
4 months of life [55, 58, 72]. Likewise, there is no scientific
basis for the avoidance of strongly allergenic foods, such as
peanuts and chicken egg, beyond this age [27, 58]. On the
contrary, there are reasons to believe that postponement of
the introduction of, for instance, peanuts until the third year
of life increases the prevalence of peanut allergy [67].
Current evidence suggests that the optimal window for the
introduction of solids in non-high-risk as well as in high-
risk children is between 4 and 6 months of age [52]—
preferably while maintaining breastfeeding until 6 months
of age [17, 52].
Breast milk mimicry
Given the apparent protective effects of breastfeeding,
interventions have been tested that aimed at mimicking
certain properties attributed to breast milk. These
include the supplementation of formula with fish oil,
probiotics and prebiotics. Recent meta-analyses, howev-
er, found insufficient evidence for a protective role of
either fish oil supplements [4], probiotics [49]o rp r e -
biotics [48]. Probiotics might even have an adverse effect
on wheezing [33].
Prevention of food allergy
Some words have to be said on the prevention of food
allergy irrespective of other manifestations of allergy.
Obviously, it can be anticipated that manipulation of the
feeding of newborn infants specifically would influence
the development of food allergy. Studies concentrating
on food allergy prevention have, however, not produced
more convincing results than other preventive studies
[24, 66].
Apparently, exposure to (traces of) foods during the
‘window’ period of 4–6 months of age may serve as a
means of inducing tolerance [29]. Early introduction of
peanut into the infants’ diet in Israel is associated with a 10
times lower prevalence of peanut allergy [24] than in Great
Britain, where peanut introduction is postponed [67]. The
effect of postponement of solids may be even more
outspoken in high-risk children [15]. The strict avoidance
of allergens, therefore, might have a contrary effect [3, 67].
Recommendations
It should be concluded that there are only limited
possibilities for allergy prevention. Table 3 gives an
overview of the advice that present scientific evidence
allows us to give to parents. Exclusive breastfeeding,
avoidance of cigarette smoke and introduction of comple-
mentary foods between 4 and 6 months of life are measures
that are applicable to all children, irrespective of their risk
assessment. When exclusive breastfeeding is impossible,
hydrolysed formula feeding might postpone mild manifes-
tations of eczema in high-risk children. There is no reason
to prefer extensively hydrolysed formula above partial
hydrolysates.
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